CF appoints new advisors to bolster our Life Sciences team

Published: 1 July 2020 

CF has made a commitment to grow its work in life sciences. We are delighted to announce that Andrew Dillon and Laurent Abuaf have agreed to join us as advisors to support our business development and where relevant client delivery.

Sir Andrew Dillon has held a number of senior management positions in the UK National Health Service, including General Manager of the Royal Free Hospital and Chief Executive of St George’s Healthcare NHS Trust, in London. He was appointed as the Founding Chief Executive of NICE, the National Institute for Health and Care Excellence in 1999, a post he held until he stepped down in 2020. He now works as an independent healthcare advisor.

Laurent Abuaf has just stepped down as the General Manager of AstraZeneca UK after more than 16 years at AZ. His prior roles have included commercial leadership roles in Europe, Asia and Global. Before joining AZ, Laurent worked for four years at BCG in a wide range of industries.  Originally from Paris, Laurent is a graduate of HEC and lives in London.

Together they will help us to understand two critical aspects to be able to support life sciences: the approach the NHS takes to valuing and adopting new medicines and the ambition of the life sciences industry in improving outcomes for patients and contributing to the development of the UK economy.

CF offers life sciences companies in depth insight and understanding of the NHS, the ability to support the development of effective partnership, clinical expertise in multiple pathways, and an award winning data science team to help access data and generate insights.